EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tintelnotia destructans: Clinical Spectrum, Laboratory Identification, and Antifungal Susceptibility

Terenzio Cosio, Brunella Posteraro, Patrizia Posteraro, Elena De Carolis, Maurizio Sanguinetti

Microorganisms · 18.11.2026 · 14 (11) · 2684

DOI: 10.3390/microorganisms14112684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 18.11.2026. Verfasst von Terenzio Cosio und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tintelnotia destructans is a rare coelomycetous mold belonging to the family Phaeosphaeriaceae. Initially described from isolates associated with keratitis and onychomycosis, it has subsequently been reported in extraocular infections, including a maxillary sinus fungus ball and invasive rhinosinusitis in an immunocompromised child. This narrative review synthesizes the clinical, diagnostic, and therapeutic evidence and reassesses publicly available sequences through single-locus and concatenated phylogenetic analyses. Twelve clinical episodes were reconstructed: eight ocular episodes, one onychomycosis, one maxillary sinus fungus ball, one invasive rhinosinusitis, and one cutaneous isolation of uncertain clinical significance. Reported ocular predisposing factors included contact lens wear, trauma, pre-existing corneal damage, and corticosteroid exposure. Laboratory identification remains challenging because morphology is insufficient for species-level recognition and MALDI-TOF MS identification depends on suitable reference spectra. ITS, LSU, and RPB2 distinguished T. destructans from T. opuntiae within the analyzed dataset, whereas SSU did not resolve the two species. The four T. destructans isolates included in the concatenated analysis showed no sequence variation. Antifungal susceptibility results derive from few isolates tested using heterogeneous methods and endpoints, without species-specific interpretive criteria. Terbinafine MICs were consistently low, but clinical superiority cannot be established; echinocandin results are difficult to compare because reported endpoints differ. Treatment regimens were heterogeneous, and several keratitis episodes required penetrating keratoplasty despite antifungal therapy. More complete clinical reporting and standardized susceptibility testing are needed to clarify the epidemiology and guide management of this uncommon opportunistic mold.

Zitieren

APA

Cosio, T., Posteraro, B., Posteraro, P., Carolis, E. D., & Sanguinetti, M. (2026). Tintelnotia destructans: Clinical Spectrum, Laboratory Identification, and Antifungal Susceptibility. Microorganisms, 14(11), 2684. https://doi.org/10.3390/microorganisms14112684

Vancouver

Cosio T, Posteraro B, Posteraro P, Carolis ED, Sanguinetti M. Tintelnotia destructans: Clinical Spectrum, Laboratory Identification, and Antifungal Susceptibility. Microorganisms. 2026;14(11):2684. doi:10.3390/microorganisms14112684

BibTeX
@article{Cosio2026,
  author = {Cosio, Terenzio and Posteraro, Brunella and Posteraro, Patrizia and Carolis, Elena De and Sanguinetti, Maurizio},
  title = {Tintelnotia destructans: Clinical Spectrum, Laboratory Identification, and Antifungal Susceptibility},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {11},
  pages = {2684},
  doi = {10.3390/microorganisms14112684}
}
Kostenlos starten →